Truist analyst Bill Chappell raised the firm’s price target for Olaplex Holdings to $15 from $10 and made no change to the firm’s Buy rating. The firm has greater conviction in the stock following 4Q22 results and continues to believe that Olaplex is one of the best growth stories in CPG, the analyst tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on OLPX:
